Bpost SA
XMUN:13B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bpost SA
XMUN:13B
|
BE |
|
Cosmo Pharmaceuticals NV
F:C43
|
IE |
|
H
|
Heidelberg Pharma AG
DUS:HPHA
|
DE |
|
Regional Management Corp
F:46F
|
US |
|
C
|
China Shenhua Energy Co Ltd
XMUN:IKF
|
CN |
|
T
|
Tele2 AB
XMUN:NCYD
|
SE |
|
UiPath Inc
NYSE:PATH
|
US |
|
Cab Payments Holdings PLC
F:2SY
|
UK |
|
D
|
DIC Asset AG
XBER:DIC
|
DE |
|
Straumann Holding AG
F:QS5
|
CH |
|
Galaxy Entertainment Group Ltd
F:KW9A
|
HK |
|
P
|
Palfinger AG
OTC:PLFRF
|
AT |
|
W
|
Wintermar Offshore Marine Tbk PT
F:W6O
|
ID |
|
Agora Inc
NASDAQ:API
|
CN |
|
Straumann Holding AG
F:QS50
|
CH |
Wall St Price Targets
13B Price Targets Summary
Bpost SA
According to Wall Street analysts, the average 1-year price target for 13B is 2.329 EUR with a low forecast of 1.719 EUR and a high forecast of 3.785 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 13B's stock price target?
Price Target
2.329
EUR
According to Wall Street analysts, the average 1-year price target for 13B is 2.329 EUR with a low forecast of 1.719 EUR and a high forecast of 3.785 EUR.
What is the Revenue forecast for Bpost SA?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Bpost SA?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Bpost SA?
Projected CAGR
45%
Over the last 13 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 3 years is 45%.
